September 17, 2024

Oxaliplatin (Eloxatin®) is a platinum-based drug used since 2002 to treat colorectal cancer. It can cause serious hypersensitivity adverse reactions and has the unique side effect of reversible peripheral sensory neuropathy exacerbated by exposure to cold temperature or objects. It gets its name from its chemical structure, which has an oxalate ligand.

September 13, 2024

In May 2022, the Centers for Disease Control and Prevention (CDC) began tracking cases of mpox (formerly named monkeypox) in the United States, a disease caused by infection with the monkeypox virus. Already in 2024, over 1,900 cases in the U.S. have been reported to the CDC. The World Health Organization declared it a global outbreak in 2022 and again in August 2024 after the clade II strain emerged. 

September 13, 2024

On September 12, 2024, the U.S. Food and Drug Administration (FDA) approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza) for subcutaneous injection for all the adult indications for the IV formulation of atezolizumab (Tecentriq®), including non-small cell lung cancer (NSCLC), small cell lung cancer, hepatocellular carcinoma, melanoma, and alveolar soft part sarcoma. 

September 12, 2024

Five months into my oncology fellowship, I was tasked with my first solo consultation during the first week of my palliative rotation. I entered the room and was struck by how young and calm Jane was.

September 06, 2024

In 2008, Feeding America established September as Hunger Action Month to bring together food banks, food pantries, and local meal programs to raise awareness about hunger and inspire people to take action. Here are some ways that you can advocate for patients with cancer who are experiencing food insecurity this month.

September 04, 2024

Equipping oncology nurses to conduct nutritional screening assessments can help reduce barriers and close gaps in the timely identification of patients with cancer who are at risk for or experiencing malnutrition, investigators reported in an article published in the Clinical Journal of Oncology Nursing. Implementing a standardized, nurse-led screening process helped their community cancer center identify that nearly 40% of their screened patients were at risk for malnutrition, while also increasing nurses’ comfort with and knowledge of cancer-related nutrition.